Skip to Content
Merck
CN
  • The hydroxamate of valproic acid, a compound produced by oximation of urine from patients under valproic therapy.

The hydroxamate of valproic acid, a compound produced by oximation of urine from patients under valproic therapy.

Biomedical & environmental mass spectrometry (1986-11-01)
R Libert, F Van Hoof, A Schanck, E Hoffmann
ABSTRACT

A previously unreported substance, detected by gas chromatography after oximation of urine from patients receiving valproic acid, was isolated and analysed by mass spectrometry and nuclear magnetic resonance spectroscopy. It was identified as the hydroxamate of valproic acid.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
VAHA, ≥98% (HPLC)